2016-06-02 SEC Press press_release 62 KB 2,853 chars

SEC Halts EB-5 Scheme Stealing Investments in Cancer Center

Release
2016-105
Caption
Securities and Exchange Commission v. Charles C. Liu, et al.
summary

Charles C. Liu and Xin 'Lisa' Wang defrauded 50 Chinese investors of $27 million through the EB-5 program by falsely promising to build a proton beam cancer center in Southern California, instead diverting $18 million to personal accounts and Chinese firms, leading to an asset freeze and SEC charges for securities fraud.

paragraph

Charles C. Liu and Xin 'Lisa' Wang raised $27 million from 50 Chinese investors via the EB-5 program, claiming the funds would build a proton beam cancer treatment center in Southern California that would create over 4,500 jobs and grant U.S. residency. Instead, they diverted $11 million to three firms in China and $7 million to their personal accounts, with no construction ever begun at the project site. The SEC charged them with violating Sections 17(a) and 10(b) of the federal securities laws, alleging deceptive marketing using unauthorized photos and letters from George H.W. Bush and Arnold Schwarzenegger, and seeks injunctions, disgorgement of ill-gotten gains, interest, and penalties.

narrative

Charles C. Liu and Xin 'Lisa' Wang raised $27 million from 50 Chinese investors through the EB-5 immigrant investor program, falsely representing that the funds would be used to build a proton beam cancer treatment center in Southern California, promising job creation and U.S. residency for investors. Despite these claims, no construction ever commenced at the proposed site after more than 18 months of collecting investments, and the couple diverted $11 million to firms in China and $7 million to their personal accounts. The SEC alleged they misled investors by fabricating government support, using photos and purported letters from former President George H.W. Bush and former California Governor Arnold Schwarzenegger—neither of whom had endorsed their uninitiated project. The court granted the SEC’s request to freeze all assets and prohibit further fundraising, recognizing the scale of the deception. The SEC charged Liu and Wang, along with their associated entities—Pacific Proton Therapy Regional Center, Pacific Proton EB-5 Fund, and Beverly Proton Center LLC—with violating antifraud provisions under Section 17(a) of the Securities Act of 1933 and Section 10(b) and Rule 10b-5 of the Securities Exchange Act of 1934. The investigation, led by the SEC’s Los Angeles office with assistance from U.S. Citizenship and Immigration Services, is ongoing, with the SEC seeking permanent injunctions, disgorgement of all ill-gotten gains plus interest and civil penalties.

Enriched metadata

Scheme
affinity-fraud (90%)
Court
Central District of California
Outcome
charged
Victim loss
$11,000,000
Classified affinity-fraud(confidence 90%). EDGAR detection: forms Form D· recall 58% / precision 2%. detection rule →
Parties
charles c. liuinvestment projectjohn berrymichele laynesec's litigationsec's los angeles regional officeSecurities and Exchange Commission
Keywords
seccentereb-cancerprotonliuinvestments cancercancer centerproton therapywangprojectinvestmentsinvestorsscheme stealingstealing investments

Extracted insights

Dollar amounts 3
  • $27.00M $27 million $10M–$100M
  • $11.00M $11 million $10M–$100M
  • $7.00M $7 million $1M–$10M
Entities 7
  • person charles c. liu
  • person investment project
  • person john berry
  • person michele layne
  • agency sec's litigation
  • agency sec's los angeles regional office
  • agency Securities and Exchange Commission
Triples 12
  • SEC announced fraud charges against Charles C. Liu and Xin Wang
  • SEC froze assets of Charles C. Liu, Xin Wang, and related entities
  • Charles C. Liu and Xin Wang raised $27 million from 50 investors in China
  • Charles C. Liu transferred $11 million in investor funds to three firms in China
  • Charles C. Liu diverted $7 million to personal accounts
  • Charles C. Liu and Xin Wang violated Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934
  • Pacific Proton Therapy Regional Center, Pacific Proton EB-5 Fund, and Beverly Proton Center LLC charged with violating antifraud provisions of securities laws
  • Charles C. Liu and Xin Wang promoted investments through EB-5 immigrant investor program
  • Investment project promised to create more than 4,500 new jobs
  • Michele Layne is Director of SEC's Los Angeles Regional Office
  • Tony Regenstreif and Lorraine L. Pearson conducted investigation supervised by Victoria A. Levin
  • John Berry will lead SEC's litigation
View original SEC press releasesec.gov
Extracted body text (2,853c)
The Securities and Exchange Commission today announced fraud charges and an asset freeze against a husband and wife accused of misusing two-thirds of the money they raised from investors for the purpose of building and operating a new cancer treatment center that would use proton beam radiation to help oncology patients in Southern California. According to the SEC’s complaint unsealed today in federal court in Los Angeles, Charles C. Liu and Xin “Lisa” Wang raised $27 million for the proton therapy cancer treatment center from 50 investors in China through the EB-5 immigrant investor program. They touted in promotional materials that the project would create more than 4,500 new jobs and have a substantial impact on the local economy while giving foreign investors an opportunity for future U.S. residency. But presently there is no construction at the proposed site after more than 18 months of collecting investments. Liu meanwhile has transferred $11 million in investor funds to three firms in China and diverted another $7 million to his and his wife’s personal accounts. In granting the SEC’s request to freeze the assets and accounts of Liu, Wang, and related entities, the court’s order prohibits them from raising further money from investors or spending remaining funds. “We allege that Liu and Wang are using investor funds as their personal piggy bank and exploiting Chinese residents who were assured they were investing in an innovative project to create jobs and cure cancer patients,” said Michele Layne, Director of the SEC’s Los Angeles Regional Office. According to the SEC’s complaint, one of the websites Liu and Wang have used to promote investments in the cancer center project includes a section entitled “Government Support” with photos of former president George Herbert Walker Bush and former California governor Arnold Schwarzenegger. Their photos are accompanied by what appear to be letters they wrote in support of proton therapy in general rather than the depicted EB-5 project, which had not even been initiated at the time the letters were written. The SEC’s complaint names Liu and Wang along with the companies behind the EB-5 project: Pacific Proton Therapy Regional Center, Pacific Proton EB-5 Fund, and Beverly Proton Center LLC. They are charged with violating antifraud provisions of Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5. The SEC seeks preliminary and permanent injunctions as well as the disgorgement of ill-gotten gains plus interest and penalties. The SEC’s investigation was conducted by Tony Regenstreif and Lorraine L. Pearson and supervised by Victoria A. Levin of the Los Angeles office. The SEC’s litigation will be led by John Berry. The SEC appreciates the assistance of U.S. Citizenship and Immigration Services.
OCR text (2,853c · plain-text · 99% conf)
The Securities and Exchange Commission today announced fraud charges and an asset freeze against a husband and wife accused of misusing two-thirds of the money they raised from investors for the purpose of building and operating a new cancer treatment center that would use proton beam radiation to help oncology patients in Southern California. According to the SEC’s complaint unsealed today in federal court in Los Angeles, Charles C. Liu and Xin “Lisa” Wang raised $27 million for the proton therapy cancer treatment center from 50 investors in China through the EB-5 immigrant investor program. They touted in promotional materials that the project would create more than 4,500 new jobs and have a substantial impact on the local economy while giving foreign investors an opportunity for future U.S. residency. But presently there is no construction at the proposed site after more than 18 months of collecting investments. Liu meanwhile has transferred $11 million in investor funds to three firms in China and diverted another $7 million to his and his wife’s personal accounts. In granting the SEC’s request to freeze the assets and accounts of Liu, Wang, and related entities, the court’s order prohibits them from raising further money from investors or spending remaining funds. “We allege that Liu and Wang are using investor funds as their personal piggy bank and exploiting Chinese residents who were assured they were investing in an innovative project to create jobs and cure cancer patients,” said Michele Layne, Director of the SEC’s Los Angeles Regional Office. According to the SEC’s complaint, one of the websites Liu and Wang have used to promote investments in the cancer center project includes a section entitled “Government Support” with photos of former president George Herbert Walker Bush and former California governor Arnold Schwarzenegger. Their photos are accompanied by what appear to be letters they wrote in support of proton therapy in general rather than the depicted EB-5 project, which had not even been initiated at the time the letters were written. The SEC’s complaint names Liu and Wang along with the companies behind the EB-5 project: Pacific Proton Therapy Regional Center, Pacific Proton EB-5 Fund, and Beverly Proton Center LLC. They are charged with violating antifraud provisions of Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5. The SEC seeks preliminary and permanent injunctions as well as the disgorgement of ill-gotten gains plus interest and penalties. The SEC’s investigation was conducted by Tony Regenstreif and Lorraine L. Pearson and supervised by Victoria A. Levin of the Los Angeles office. The SEC’s litigation will be led by John Berry. The SEC appreciates the assistance of U.S. Citizenship and Immigration Services.